SS Innovations International Marks Major Milestone With India’s First Robotic Telesurgery Marathon

SS Innovations International Inc, the developer of India’s first indigenous surgical robotic system, SSII Mantra, has achieved a major milestone in technology-enabled healthcare by successfully completing 100 robotic telesurgeries. To commemorate this achievement, the company hosted India’s first-ever Marathon Robotic Telesurgery, during which more than 20 tele-enabled robotic surgeries were performed in a single day, demonstrating the safety, precision and scalability of indigenous robotic surgery technology.

The milestone marks a significant advancement in the evolution of remote surgical care in India and highlights the growing role of telesurgery in bridging healthcare gaps across the country. By enabling expert surgeons to operate on patients located far away using advanced robotic systems, SS Innovations International has showcased how high-quality surgical care can be delivered reliably across geographical boundaries.

According to the company, the Marathon Robotic Telesurgery served as a real-world clinical validation of the SSII Mantra platform. The successful completion of multiple surgeries across specialties in a single day reinforced the system’s robustness, responsiveness and clinical maturity. It also demonstrated the platform’s ability to function consistently under demanding conditions, a critical requirement for scaling telesurgery across diverse healthcare settings.

India’s vast population of over 1.4 billion people continues to face uneven access to advanced surgical care, particularly in smaller cities and remote regions. SS Innovations International said telesurgery has the potential to transform this landscape by allowing highly skilled surgeons based in major medical centres to remotely operate on patients in underserved areas. This approach can reduce the need for patient travel, shorten waiting times, and ensure timely intervention for complex medical conditions.

Dr Sudhir Srivastava, Founder, Chairman and Chief Executive Officer of SS Innovations International Inc, described the completion of 100 telesurgeries as a defining moment for Indian medical technology. “Completing 100 telesurgeries with SSII Mantra represents a landmark achievement for indigenous medtech innovation. The Marathon Robotic Telesurgery is a real clinical demonstration of scale, precision and reliability. Our mission is to ensure that advanced surgical care is no longer restricted by geography, and that world-class expertise developed in India can reach patients everywhere through safe and dependable technology,” he said.

The marathon event brought together leading surgeons from across the country and multiple medical disciplines, highlighting the versatility of the SSII Mantra system. Experts from oncology, urology, bariatric surgery, cardiothoracic surgery and other specialties participated in the telesurgeries, underscoring the system’s broad clinical applicability.

Dr Sudhir Rawal, Medical Director and Chief of Uro-Genito Oncology at Rajiv Gandhi Cancer Institute and Research Centre, said robotic telesurgery could play a crucial role in expanding access to specialised cancer care. “Robotic telesurgery using SSII Mantra enables precise and timely cancer treatment for patients who may otherwise lack access to specialised surgical expertise. This milestone reflects a meaningful shift in how oncology care can be delivered at scale,” he noted.

Echoing similar views, Dr Mohit Bhandari, President of IRCAD India and Director of Bariatric Surgery at Mohak Bariatrics and Robotics, said the achievement establishes telesurgery as a practical solution rather than a concept for the future. “This demonstrates that complex procedures can be decentralised without compromising clinical outcomes. Telesurgery is no longer experimental—it is ready for real-world application,” he said.

Dr Chandramohan Vaddi, Managing Director and Head of Urology at Preeti Urology and Kidney Hospitals in Hyderabad, emphasised the confidence the system provides to surgeons. “The consistency and responsiveness of the SSII Mantra system during telesurgery strengthens surgeon confidence and expands the scope of performing complex urological procedures remotely,” he said.

Cardiothoracic and vascular surgeon Dr Lalit Malik of Manipal Hospital highlighted the system’s reliability in high-precision fields. “Specialties such as cardiac surgery demand absolute reliability and precision. The performance demonstrated by SSII Mantra during telesurgery highlights its robustness and growing relevance for advanced remote cardiac care,” he said.

Dr Magan Mehrotra, Senior Bariatric and Robotic Surgeon at Apex Hospital, Moradabad, said the initiative showed how indigenous technology could bring advanced healthcare closer to people living outside major urban centres. “This Marathon Robotic Telesurgery illustrates how home-grown innovation can deliver advanced surgical care to smaller cities and underserved regions, making healthcare not just accessible but also more affordable for the masses,” he said.

With the successful completion of 100 telesurgeries and India’s first Marathon Robotic Telesurgery, SS Innovations International said it has demonstrated the readiness of the SSII Mantra platform for wider adoption. The company believes the milestone strengthens India’s position as an emerging global leader in medical technology and robotic surgery.

SS Innovations International said it remains committed to expanding access to safe, high-quality surgical care through continuous innovation and collaboration with healthcare providers. As the global healthcare industry increasingly adopts technology-enabled and remotely delivered solutions, the company aims to play a key role in shaping the future of surgery.

SS Innovations International Inc, listed on Nasdaq under the ticker SSII, develops innovative surgical robotic technologies with the vision of making robotic surgery affordable and accessible to a larger segment of the global population. Its product portfolio includes the SSII Mantra surgical robotic system and the SSII Mudra range of surgical instruments, which support a wide variety of procedures, including robotic cardiac surgery. Headquartered in India, the American company plans to expand its global footprint by offering technologically advanced, user-friendly and cost-effective robotic surgical solutions worldwide.